Riverside’s private equity portfolio


Return to Portfolio Search


Stemlab is a pioneer and leader in Portugal in isolation and cryopreservation of stem cells from umbilical cord blood. If necessary, these cells can be used by the family to treat future ailments since stem cells are the precursors to most specialized cells in the body and can be used to help treat a variety of illnesses.

Acquired :
October 2009
Exited :
September 2018
Industry :
Consumer Brands , Healthcare
Region :
Location :
Cantanhede, Portugal
Add-on Acquisitions :

Celvitae Biomédica S.A. of Madrid, Spain (July 2010)

Website :
News Releases :
Riverside Acquires Portuguese Provider of Cryopreservation and Isolation of Umbilical Cord Stem Cells
Riverside Completes Its First Deal In Spain